Evidence map›Paper›PMID 42902866›Full record

ArticleAging cell2026

Cellular Senescence Dysregulates Antiviral Interferon Responses in Idiopathic Pulmonary Fibrosis.

Jun-Wei B Hughes, Yasmina Reisser, Franziska Hornung, Tyler A U Hilsabeck, Fiona Senchyna, Ana L Coelho, Tsung-Che Ho, Kevin Schneider, David Furman, Cory M Hogaboam and 3 more

Abstract read
In one paragraph

Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jun-Wei B HughesBuck Institute for Research on Aging, Novato, California, USA.ORCID https://orcid.org/0000-0003-1887-0242
Yasmina ReisserInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.ORCID https://orcid.org/0009-0007-9757-5036
Franziska HornungInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.
Tyler A U HilsabeckBuck Institute for Research on Aging, Novato, California, USA.ORCID https://orcid.org/0000-0002-1690-4704
Fiona SenchynaBuck Institute for Research on Aging, Novato, California, USA.ORCID https://orcid.org/0009-0006-3504-1269
Ana L CoelhoCedars-Sinai, Los Angeles, California, USA.
Tsung-Che HoUniversity of California, San Francisco, San Francisco, California, USA.
Kevin SchneiderBuck Institute for Research on Aging, Novato, California, USA.
David FurmanBuck Institute for Research on Aging, Novato, California, USA.ORCID https://orcid.org/0000-0002-3654-9519
Cory M HogaboamCedars-Sinai, Los Angeles, California, USA.ORCID https://orcid.org/0000-0003-3366-4850
Claude Jourdan Le SauxUniversity of California, San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-6041-2870
Pierre-Yves DesprezBuck Institute for Research on Aging, Novato, California, USA.
Stefanie Deinhardt-EmmerInstitute of Medical Microbiology, Jena University Hospital, Jena, Germany.ORCID https://orcid.org/0000-0003-4495-4052

Funding

Single cell analysis coreP01AG066591 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI ELLERBY, LISA M · 2021 to 2025
$15.5M
USC Geroscience Training in the Biology of AgingT32AG052374 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Sean P CURRAN · 2016 to 2026
$5.3M
BMFTR (Bundesministerium für Forschung, Technologie und Raumfahrt) 13N15745NIA NIH HHS P01 AG066591NIA NIH HHS P01AG066591NIA NIH HHS T32 AG052374NIA NIH HHS T32AG052374
6 · The paper itself

Abstract

Patients with idiopathic pulmonary fibrosis (IPF) are highly vulnerable to respiratory virus infections, but the cellular mechanisms linking fibrotic remodeling to impaired local antiviral defense remain unclear. Here, we investigated how cellular senescence shapes the response of patient-derived healthy (HLF) and IPF primary lung fibroblasts to influenza A virus (IAV) infection. Transcriptomic profiling identified infection as the driver of gene expression in both DNA damage-induced senescent HLF and IPF fibroblasts and revealed induction of canonical antiviral pathways in both cell states. However, senescent IPF fibroblasts adopted a distinct antiviral response state characterized by a broader set of uniquely induced genes and differential coordination of antiviral transcriptional networks. Functionally, senescence increased viral titers in HLF and IPF fibroblasts, while senescent IPF fibroblasts displayed an altered inflammatory response. Network analysis linked viral response- and cell cycle-associated modules specifically to the senescent HLF infected state, whereas these programs were weaker in senescent IPF fibroblasts. Transcription factor inference identified IRF3 and STAT1 as candidate regulators of this altered antiviral state in both senescent HLF and IPF fibroblasts. Consistent with the network and transcription factor analyses, siRNA-mediated depletion of IRF3 or STAT1 significantly reduced IFN-β secretion in senescent HLF fibroblasts, whereas IPF fibroblasts showed only milder effects, indicating a disease-specific dependence on these pathways for antiviral control. Together, these findings show that the combination of cellular senescence and fibrotic fibroblast identity creates a dysfunctional antiviral state that may help explain the high susceptibility of IPF patients to virus-associated acute exacerbations and disease worsening.

Indexed as

Cellular SenescenceIdiopathic Pulmonary FibrosisInterferonsCells, CulturedFibroblastsHumansInfluenza A virusInterferon Regulatory Factor-3STAT1 Transcription FactorInterferon Regulatory Factor-3InterferonsSTAT1 protein, humanSTAT1 Transcription Factorcellular senescenceidiopathic pulmonary fibrosisinfluenza A virusinterferon signalingIRF3/STAT1lung fibroblasts

Identifiers

PMID42902866
PMCPMC13684319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.